Top Markets
#1 EXOD EXOD +9.04%
#2 MarsCoin MarsCoin +9.00%
#3 Akedo Akedo +8.33%
#4 Solstice Solstice +8.24%
#5 peaq peaq +8.13%
#6 ETHGas ETHGas +7.27%
#7 龙虾 (Lobster) 龙虾 (Lobster) +6.51%
#8 Wrapped Flare Wrapped Flare +6.34%
#9 Official Trump Official Trump +6.27%
#10 Peapods Finance Peapods Finance +6.22%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
BELLUS Health Inc. BELLUS Health Inc.

BELLUS Health Inc.

BLU
Rank in Stocks #6896
BELLUS Health Inc. is a biopharmaceutical firm in the clinical development... BELLUS Health Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to creating new therapeutic options for intractable chronic cough (RCC) and various other conditions characterized by heightened cough sensitivity. The company's primary investigational compound, BLU-5937, functions as a P2X3 receptor antagonist. This drug is currently progressing through Phase II clinical trials, where it is being assessed for its potential in treating both RCC and persistent itching. Founded in 1993, BELLUS Health Inc. is headquartered in Laval, Canada.
Share Price
$14.30
Last synced: 2023-06-29
Market Cap
$1.81B
Change (1 day)
-2.81%
Change (1 year)
0.00%
Country
CA
Trade BELLUS Health Inc. (BLU)

Category

Healthcare
Earnings for BELLUS Health Inc. (BLU)
Earnings in 2026 TTM: 0
According to BELLUS Health Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for BELLUS Health Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH